Remove Degenerative Disc Disease Remove Lower Back Pain Remove Presentation
article thumbnail

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

OrthoSpineNews

The following is breakdown of the percentage of subjects that had both a greater than 50% improvement in function, as measured by ODI, and a greater than 50% decrease in pain, as measured by VAS: Week Percentage of Subjects with a Greater than 50% improvement in Both ODI and VAS 2 0.0% 12 13.33% 26 46.15% 52 70.0%

article thumbnail

Chiropractic Care: Your Ultimate Solution for Chronic Back Pain Relief

Any Spine

This level of pain not only necessitates frequent visits to physicians but can also lead to a significant increase in medical expenses, often with numerous insurance claims. It is a pervasive disease, silently exacting its toll on the physical and mental well-being of sufferers and their support systems alike.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Comprehensive Guide to Spine Pain Causes and Chiropractic Solutions

Any Spine

Occurrences of degenerative disc disease are common where the intervertebral discs lose their flexibility, leading to chronic back pain and reduced mobility. Identifying Common Causes of Spine Pain Spine pain, a prevalent concern for many, can stem from various sources.

Spine 52
article thumbnail

Effective Chiropractic Strategies for Alleviating Lower Spine Pain

Any Spine

As such, this persistent pain often escalates into a hindrance that demands effective management strategies to restore quality of life. Furthermore, the reliance on medications such as opioids for spine pain relief presents a significant concern due to the risk of dependency and side effects.

Spine 52
article thumbnail

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

OrthoSpineNews

We are excited by the trajectory of this material milestone and its potential to address a massive unmet need in chronic lower back pain — one of the largest global healthcare burdens. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

article thumbnail

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

OrthoSpineNews

Disc/Spine Program In a February podium presentation at the Orthopaedic Research Society (ORS) Annual Meeting, BioRestoratives Vice President of Research and Development, Francisco Silva, presented 2652 week blinded data from the first 15 patients with chronic lumbar disc disease (cLDD) enrolled in the ongoing Phase 2 clinical trial of BRTX-100.